Immunogenicity 15765
Sample ID
3784
Response
Positive
Tumor Type
Melanoma
Gene Symbol
GNB5
Transcript ID
None
HLA INFO
B*07:02
TCR INFO
CDR3ACAVRDNYGQNFVF
TRBVBV27
TRAVAV36
CDR3BCASSLSWGSSYNEQFF
Full length protein sequence (353 aa)
MAYLS
1
CRDSV
6
CPSYT
11
STQLG
16
RLRPS
21
PTSTT
26
GWLEL
31
QDMHQ
36
VAERV
41
EALGQ
46
FVMKT
51
RRTLK
56
GHGNK
61
VLCMD
66
WCKDK
71
RRIVS
76
SSQDG
81
KVIVW
86
DSFTT
91
NKEHA
96
VTMPC
101
TWVMA
106
CAYAP
111
SGCAI
116
ACGGL
121
DNKCS
126
VYPLT
131
FDKNE
136
NMAAK
141
KKSVA
146
MHTNY
151
LSACS
156
FTNSD
161
MQILT
166
ASGDG
171
TCALW
176
DVESG
181
QLLQS
186
FHGHG
191
ADVLC
196
LDLAP
201
SETGN
206
TFVSG
211
GCDKK
216
AMVWD
221
MRSGQ
226
CVQAF
231
ETHES
236
DINSV
241
RYYPS
246
GDAFA
251
SGSDD
256
ATCRL
261
YDLRA
266
DREVA
271
IYSKE
276
SIIFG
281
ASSVD
286
FSLSG
291
RLLFA
296
GYNDY
301
TINVW
306
DVLKG
311
SRVSI
316
LFGHE
321
NRVST
326
LRVSP
331
DGTAF
336
CSGSW
341
DHTLR
346
VWA
351
Mutation Information
DNA mutation:
None
Peptide Range:
327 ~ 335
Mut AA position:
None (9 in Wild Type peptide)
Alignment
Wild Type:
"RVSTLRVSP
||||||||.
Mutant:
RVSTLRVSL"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) GNB5
Checkpoint
Blockade
None
ACT
N
Vaccination
N
Curative
Effect
None
minimal_peptide
Y
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
DCs
Assay
None